Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MeadowBrook Investment Advisors LLC acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 1,165 shares of the biopharmaceutical company’s stock, valued at approximately $94,000. Several other hedge funds have also recently modified their holdings […]
MeadowBrook Investment Advisors LLC purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 1,165 shares of the biopharmaceutical company’s stock, valued at approximately $94,000. A number of other hedge funds and other institutional investors have also recently added to or […]
Gallacher Capital Management LLC raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 28.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 5,585 shares of the biopharmaceutical company’s stock after buying an additional 1,237 shares during the period. Gallacher Capital Management LLC’s holdings […]
Merit Financial Group LLC reduced its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 36.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,278 shares of the biopharmaceutical company’s stock after selling 6,994 shares […]
Avidian Wealth Solutions LLC increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,148 shares of the biopharmaceutical company’s stock after purchasing an additional 259 […]